Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 × 106/l CD4 cells treated with highly active antiretroviral therapy

Autor: Lucia Ercoli, Ercole Concia, M Mannazzu, Giuseppe Tridente, Antonio Aceti, Loredana Sarmati, Giorgio Mancino, Emanuele Nicastri, Giovanni Sotgiu, Marco Trevenzoli, Massimo Andreoni, Saverio Giuseppe Parisi
Rok vydání: 2000
Předmět:
Zdroj: AIDS. 14:23-29
ISSN: 0269-9370
Popis: To evaluate the decay rate of cellular proviral HIV-DNA and viral replication in patients receiving highly active antiretroviral therapy (HAART) in the very early phase of infection.Thirty-four patients treated with HAART and retrospectively selected for progressive decline of plasma viraemia up to undetectable levels (20 copies/ml), were stratified according to CD4+ cell count and plasma viraemia at base line:500 x 10(6) cells/l with5000 copies/ml (group 1) or with5000 copies/ml (group 2),5000 copies/ml with 300-500 x 10(6) cells/l (group 3) or with300 x 10(6) cells/l (group 4). Plasma HIV-RNA and proviral HIV-DNA were analysed at baseline and after 1, 2, 3, 6, 9 and 12 months of treatment.After 1 year of treatment, a significant decrease of proviral DNA titre was observed in all patients and a decrease1 log was achieved in 24 of 29 subjects of the first three groups. The more pronounced decay of HIV-DNA (half-life 28 weeks) up to50 HIV-DNA copies/10(6) CD4+ cells was detected in patients of group 1. At the year's endpoint, five patients (four in group 1 and one in group 2) had20 HIV-DNA copies. However, HIV strains sensitive to antiretroviral drugs were isolated from peripheral lymphocytes of 16 out of 34 patients.In patients with undetectable plasma viraemia after 1 year of HAART, the highest reduction of proviral DNA up to50 copies/10(6) CD4+ cells was obtained only in subjects in the early asymptomatic phase of infection. Nevertheless, a replication-competent virus can be detected in all phases of antiretroviral therapy.
Databáze: OpenAIRE